Milestone Scientific (MLSS) Common Equity (2010 - 2026)

Milestone Scientific (MLSS) has 17 years of Common Equity data on file, last reported at $2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 48.8% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $2.3 million (down 48.8% YoY), and the FY2025 full-year result was $2.8 million, down 51.78% from the prior year.
• Common Equity declined to $2.3 million in Q1 2026, from $2.8 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $14.8 million in Q1 2022 to a low of $2.3 million in Q1 2026.
• A 5-year average of $7.3 million and a median of $7.5 million in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity gained 3.27% in 2024 and slumped 64.7% in 2025, its largest moves.
• Tracing MLSS's Common Equity over 5 years: stood at $10.0 million in 2022, then slipped by 19.93% to $8.0 million in 2023, then dropped by 27.21% to $5.8 million in 2024, then slumped by 51.78% to $2.8 million in 2025, then retreated by 18.76% to $2.3 million in 2026.
• Business Quant data shows MLSS's Common Equity at $2.3 million in Q1 2026, $2.8 million in Q4 2025, and $2.5 million in Q3 2025.